Filing Details
DataMeds AI, Inc. (NASDAQ:MEDS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 17, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:MEDS
DataMeds AI, Inc. (MEDS) Files Quarterly Report for Q0
DataMeds AI, Inc. (NASDAQ:MEDS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 17, 2026.
At publication ·
What changed
DataMeds AI, Inc. (NASDAQ:MEDS) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- DataMeds AI, Inc. (NASDAQ: MEDS) filed its Q0 quarterly report (Form 10-Q) on August 17, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $1.49 with a market capitalization of $13.3 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
DataMeds AI, Inc.'s stock currently trades at $1.49 with a market capitalization of $13.3M.
The 10-Q provides DataMeds AI, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for DataMeds AI, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MEDS Stock Page
Frequently Asked Questions
Where can I read MEDS's SEC filings?
Browse all filings on our MEDS SEC filings page.
What types of SEC filings does DataMeds AI, Inc. file?
Public companies like DataMeds AI, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.